Latest Ipsen News & Updates

See the latest news and media coverage for Ipsen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ipsen

Global specialty biopharmaceutical company

ipsen.com

Headquarters: Paris, France
Company type: Public company
Number of employees: 6,500–10,000

Last updated Today

Latest news about Ipsen

In short: Ipsen reported 22.6% sales growth in Q1 2026, secured EU approval for Ojemda, and voluntarily withdrew Tazverik from all markets due to safety risks.

Company announcements

June 15 Ipsen

Ipsen announces weekly share buy-back transactions under MAR

Between June 8 and 12, 2026, Ipsen repurchased 13,712 shares at a weighted average price of €156.73 per share.

June 9 Ipsen

Ipsen welcomes EU publication of Joint Clinical Assessment for Ojemda

The assessment confirms challenges in generating comparative evidence for this rare tumor, and Ojemda is the first approved targeted therapy in this setting.

June 5 Ipsen

Ipsen releases its 2025 Integrated Annual Report

The report details progress in strategy, partnerships, pipeline, and sustainability, highlighting impact for patients.

May 28 Ipsen

Ipsen presents new data on IQIRVO for PBC

Late-breaking results show fatigue improvements and ALP normalization in real-world studies, reinforcing IQIRVO's efficacy.

Media coverage

Yesterday Six Actualités

Ipsen posts spectacular sales growth in first quarter 2026 and confirms its strategic ambitions

Ipsen posts spectacular sales growth in first quarter 2026 and confirms its strategic ambitions, marking a key step in its trajectory on...

June 12 ZoneBourse

Abivax, Ipsen and Soitec join the CAC Next 20

Following its quarterly review of the CAC 40 family indices, Euronext announces the inclusion of pharmaceutical companies Abivax and Ipsen, as well as the...

June 9 Daily Political

What is HC Wainwright’s Forecast for IPSEN FY2026 Earnings? - Daily Political

IPSEN (OTCMKTS:IPSEY – Free Report) – Equities researchers at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for IPSEN in a report issued...

June 8 ZoneBourse

Ipsen: Threshold crossing and declaration of intention

226C0788 FR0010259150-FS0497-DER02 June 5, 2026 Declaration of crossing of thresholds and declaration of intention...

Never miss news about Ipsen

Track Ipsen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ipsen competitors & trending companies

Browse news for competitors to Ipsen and other trending companies.